title: Siltuximab (Sylvant) for treatment of multicentric castleman's disease.
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005871:Castleman Disease / Q000175:diagnosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000379:methods; D006801:Humans
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; C504234:siltuximab